The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Acadia Pharmaceuticals Inc Common 004225108 3,675 151,750 SH   SOLE   151,750 0 0
ADC Therapeutics, Inc. Common H0036K147 4,912 334,384 SH   SOLE   334,384 0 0
Amicus Therapeutics Inc. Common 03152W109 4,693 495,603 SH   SOLE   495,603 0 0
Arcutis Biotherapeutics inc Common 03969K108 4,979 258,500 SH   SOLE   258,500 0 0
Avadel Pharmaceuticals Plc ADR 05337M104 2,816 412,363 SH   SOLE   412,363 0 0
AVROBIO, Inc. Common 05455M100 855 647,918 SH   SOLE   647,918 0 0
Axsome Therapeutics Inc. Common 05464T104 4,132 99,834 SH   SOLE   99,834 0 0
Biocryst Pharmaceuticals Inc. Common 09058V103 10,392 639,089 SH   SOLE   639,089 0 0
Black Diamond Therapeutics, Inc. Common 09203E105 664 239,888 SH   SOLE   239,888 0 0
Crinetics Pharmaceuticals Inc. Common 22663K107 8,049 366,676 SH   SOLE   366,676 0 0
Cullinan Oncology, Inc. Common 230031106 80,077 7,648,268 SH   SOLE   7,648,268 0 0
Cytokinetics Inc. Common 23282W605 8,254 224,246 SH   SOLE   224,246 0 0
Epizyme, Inc. Common 29428V104 3,939 3,425,202 SH   SOLE   3,425,202 0 0
ESSA Pharma, Inc. Common 29668H708 4,084 660,892 SH   SOLE   660,892 0 0
G1 Therapeutics, Inc. Common 3621LQ109 6,512 856,798 SH   SOLE   856,798 0 0
Geron Corporation Common 374163103 8,363 6,149,277 SH   SOLE   6,149,277 0 0
Harmony Biosciences Hldgs Inc. Common 413197104 6,690 137,517 SH   SOLE   137,517 0 0
Harpoon Therapeutics, Inc. Common 41358P106 15,888 3,196,707 SH   SOLE   3,196,707 0 0
Inozyme Pharma Inc. Common 45790W108 1,206 294,980 SH   SOLE   294,980 0 0
Intellia Therapeutics, Inc. Common 45826J105 11,584 159,409 SH   SOLE   159,409 0 0
iTeos Therapeutics, Inc. Common 46565G104 56,184 1,745,943 SH   SOLE   1,745,943 0 0
Karuna Therapeutics inc Common 48576A100 2,536 20,000 SH   SOLE   20,000 0 0
Merus N.V. Common N5749R100 24,311 919,482 SH   SOLE   919,482 0 0
Mirum Pharmaceuticals Inc. Common 604749101 6,353 288,531 SH   SOLE   288,531 0 0
Neogenomics Inc. Common 64049M209 1,647 135,573 SH   SOLE   135,573 0 0
Oncorus, Inc. Common 68236R103 4,231 2,377,031 SH   SOLE   2,377,031 0 0
Phathom Pharmaceuticals inc Common 71722W107 2,631 193,326 SH   SOLE   193,326 0 0
Reata Pharmaceuticals inc-a Common 75615P103 5,897 180,000 SH   SOLE   180,000 0 0
Relmada Therapeutics inc Common 75955J402 3,725 138,000 SH   SOLE   138,000 0 0
Repare Therapeutics, Inc. Common 760273102 23,351 1,639,849 SH   SOLE   1,639,849 0 0
Revolution Medicines, Inc. Common 76155X100 3,726 146,041 SH   SOLE   146,041 0 0
TCR2 Therapeutics, Inc. Common 87808K106 9,304 3,370,982 SH   SOLE   3,370,982 0 0
Travere Therapeutics Inc. Common 89422G107 7,163 277,950 SH   SOLE   277,950 0 0
Turning Point Therapeutics, Inc. Common 90041T108 9,434 351,350 SH   SOLE   351,350 0 0
Verastem, Inc. Common 92337C104 4,575 3,244,650 SH   SOLE   3,244,650 0 0
Werewolf Therapeutics, Inc. Common 95075A107 10,507 2,388,011 SH   SOLE   2,388,011 0 0
YmAbs Therapeutics, Inc. Common 984241109 5,271 443,702 SH   SOLE   443,702 0 0